Moreover, how PLD3 or genetic variants functionally contribute to the AD-linked pathogenic processes has not been determined, and the consequences of the AD-linked genetic variants on the enzyme’s function are still unknown. This evidence concerns the gene PLD3 and Alzheimer disease.